Tempus Priority Study: A Pan-tumor Observational Study

Recruiting

• Conditions: Breast Cancer; Prostate Cancer; Bladder Cancer; Lung Cancer; Brain Cancer; Pancreatic Cancer; Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Cancer of Liver

• Registration Number: NCT05179824
• Lead Sponsor: Tempus AI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-16
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> 1. Solid or hematologic malignancy.<br><br> 2. Willing and able to provide informed consent where required.<br><br> 3. Has received or will receive genomic profiling.<br><br>Exclusion Criteria:<br><br> 1. Individuals without the capacity to consent.<br><br> 2. Prisoners at the time of enrollment.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Create robust data set of health information

Secondary Outcome Measures

Name	Time	Method
Document clinical events for patients who have had comprehensive genomic profiling;Evaluate longitudinal paired tissue and cell free molecular testing